Thank You. Since fenofibrate and glyburide-metformin compete for protein-binding sites in the plasma and as a result both drugs are increased in the blood, possible leading to hypoglycemia, should one stop the fenofibrate in a Type II diabetic patient?
Hello,Fenofibrate  ChatDoctor.  That sometimes may also reduce the dosage of anti-diabetic